CRL News and Press, Charles River Laboratories International Inc. From 05/09/24

2024-05-09 19:00:06 ET Elizabeth Anderson from Evercore ISI issued a price target of $265.00 for CRL on 2024-05-09 16:15:00. The adjusted price target was set to $265.00. At the time of the announcement, CRL was trading at $230.09. The overall price target consensus is a...

2024-05-09 16:46:02 ET More on Charles River Laboratories Charles River Laboratories International, Inc. (CRL) Q1 2024 Earnings Call Transcript Charles River Laboratories: Weak Biopharma Spending Is Transitory; Initiate With 'Hold' Read the full article on Seeking ...

2024-05-09 12:35:25 ET Charles River Laboratories International, Inc. (CRL) Q1 2024 Results Conference Call May 09, 2024 8:30 AM ET Company Participants Todd Spencer - VP, IR Jim Foster - Chair, President & CEO Flavia Pease - EVP, CFO Conference Call Pa...

2024-05-09 07:14:14 ET More on Charles River Laboratories Charles River Laboratories: Weak Biopharma Spending Is Transitory; Initiate With 'Hold' Charles River Laboratories International, Inc. (CRL) Q4 2023 Earnings Call Transcript Charles River Laboratories Q1 2024 ...

AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...

– First-Quarter Revenue of $1.01 Billion – – First-Quarter GAAP Earnings per Share of $1.30 and Non-GAAP Earnings per Share of $2.27 – – Updates 2024 Guidance – Charles River Laboratories International, Inc. (NYSE: CRL) today rep...

2024-05-08 11:40:40 ET More on Charles River Laboratories Charles River Laboratories: Weak Biopharma Spending Is Transitory; Initiate With 'Hold' Charles River Laboratories International, Inc. (CRL) Q4 2023 Earnings Call Transcript Charles River, Axovia to collaborat...

2024-05-05 09:52:16 ET More on the markets S&P 500 1%+ Gaps Higher SPY: Don't Buy The Dip Just Yet Rate Hike Unlikely: Expect S&P 500 To Rally To New All-Time Highs Dovish Fed, 'Goldilocks' jobs report helps S&P 500 notch back-to-back weekly gains...

Supporting scale-up for early-phase AAV- and LVV-based gene and gene-modified cell therapy researchers and developers Charles River Laboratories International, Inc. (NYSE: CRL) today announced the launch of its reference materials for adeno associated virus (AAV) and lentiviral vector (...

2024-04-29 13:17:15 ET More on S&P 500 Index: Soft Landing On Track, With New All-Time Highs Ahead Yen Dumps Before It Jumps S&P 500: Trade Of The Year. Week Starting 29th April (Technical Analysis) Nasdaq, S&P, and Dow rise with the latest Fed de...